Telomir Pharmaceuticals (TELO) has recently gained significant attention following a local ABC exclusive that showcased impressive results from their novel "age reversal" pill in two senior dogs. This compassionate use study has sparked interest in Telomir's stock.

This article What if you could ‘grow younger’? Meet the new pill that’s redefining what’s possible for aging bodies, starting with our furry friends! 🧬 appeared first on Guerilla Stock Trading.

On July 31, 2024, Cassava Sciences (SAVA) stock surged by 26.47%, closing at $22.22, driven by several positive…

This article New leadership, new hope? Cassava Sciences sees a 26.47% rise amid Phase 3 trial news and high patient retention 📊 appeared first on Guerilla Stock Trading.

On July 25, 2024, Psyence Biomedical (PBM) stock surged by approximately 163% due to two significant updates: the…

This article PBM stock skyrockets 163% after game-changing export approval and clinical trial breakthroughs! 🚀 appeared first on Guerilla Stock Trading.

On July 25, 2024, Predictive Oncology (POAI) stock surged due to the company’s expansion into the biomarker discovery…

This article Predictive Oncology just made a game-changing move! Their AI-driven platform is now tackling biomarker discovery, investors are thrilled! 🔬 appeared first on Guerilla Stock Trading.

Cellectar Biosciences (CLRB) stock is rising due to several positive developments. The company reported a 64% complete remission…

This article Big wins in the fight against cancer! Cellectar’s drug delivery shows 20x efficiency over standard therapies 🎉 appeared first on Guerilla Stock Trading.

Scinai Immunotherapeutics (NASDAQ: SCNI) recently saw an 88% increase in its stock price, driven by high trading volume,…

This article Major moves for SCNI! European Investment Bank’s $28M equity conversion shakes up the market! 💡 appeared first on Guerilla Stock Trading.

Eli Lilly plans to acquire Morphic Therapeutics, a biotechnology company, for $3.2 billion in an all-cash deal. Morphic,…

This article Eli Lilly is making a game-changing move in healthcare with a $3.2 billion acquisition! 💊 appeared first on Guerilla Stock Trading.

Eli Lilly has reported a strong performance in the first quarter of 2024, continuing the momentum from 2023…

This article Mounjaro & Zepbound Drive Eli Lilly’s Revenue Sky-High in Q1 appeared first on Guerilla Stock Trading.

In a groundbreaking clinical trial conducted by Novo Nordisk four years ago, a drug called semaglutide demonstrated remarkable…

This article The Obesity Drug Revolution: A New Era in Weight Loss Treatment appeared first on Guerilla Stock Trading.

Amgen’s Q1 earnings report showcased a notable 22% increase in revenue, hitting $7.4 billion, aligned with expectations, while…

This article Amgen’s Q1 2024 Earnings: $7.4B Revenue Surge! appeared first on Guerilla Stock Trading.

In a groundbreaking development, Ohio State University researchers have unveiled CURE, an Artificial Intelligence (AI) model poised to…

This article Unlocking the Future of Medicine: Introducing CURE appeared first on Guerilla Stock Trading.

In the realm of healthcare, the landscape is continually evolving, with breakthroughs in technology often spearheading monumental shifts.…

This article Artificial Intelligence: A Game-Changer in Disease Treatment appeared first on Guerilla Stock Trading.

In the realm of pharmaceuticals, innovation often leads the way to groundbreaking treatments and advancements in healthcare. Recently,…

This article Revolutionizing Cardiovascular Treatment: Novo Nordisk’s Strategic Expansion appeared first on Guerilla Stock Trading.

In a groundbreaking development, Bristol Myers Squibb (BMY) recently announced promising results for their cancer pill, Krazati, in…

This article Bristol Myers Squibb’s Krazati: A Potential Game Changer in Cancer Treatment appeared first on Guerilla Stock Trading.

In the realm of healthcare, the integration of artificial intelligence (AI) has sparked a revolution, promising unprecedented breakthroughs…

This article The Impact of Artificial Intelligence on Drug Development: A Glimpse into the Future appeared first on Guerilla Stock Trading.

In the dynamic landscape of biotechnology, collaboration often paves the way for groundbreaking advancements. Such is the case…

This article AbCellera and Biogen Join Forces to Tackle Brain Diseases: A Promising Partnership appeared first on Guerilla Stock Trading.

The healthcare industry stands on the cusp of a revolutionary transformation, driven by the rapid advancements in artificial…

This article Artificial Intelligence Revolutionizing Healthcare appeared first on Guerilla Stock Trading.

The realm of healthcare has long been a domain of innovation and progress, with each advancement promising a…

This article Unlocking the Future of Healthcare: The AI-Powered Revolution appeared first on Guerilla Stock Trading.

BridgeBio Pharma (BBIO) has taken a significant step forward in its quest to address a rare heart condition,…

This article BridgeBio Pharma’s Strategic Partnership with Bayer appeared first on Guerilla Stock Trading.

Throughout its history, the pharmaceutical industry has primarily relied on pills and proteins to treat various diseases. However,…

This article The Emergence of Genetic Treatments: Revolutionizing the Drug Industry appeared first on Guerilla Stock Trading.

This article The Role of AI in Roivant Sciences’ Success appeared first on Guerilla Stock Trading.

This article Harnessing AI in Biotechnology: A New Era of Drug Discovery and Development appeared first on Guerilla Stock Trading.

This article The Potential Health-Care Sector Comeback: Biotech and Medtech in Focus appeared first on Guerilla Stock Trading.

This article BullFrog AI’s Breakthrough Collaboration with LIBD: A Revolution in Psychiatric Research appeared first on Guerilla Stock Trading.